Pharmaceutical Industry Information Portal

HomeManufacturers News

Manufacturers News

GEROPHARM brings back Ozempic® with a new name: Semavic®

To expand on the news about GEROPHARM's release of Semavic®, the company has introduced Semavic® as a domestic analogue to Ozempic®, responding to the cessation of Ozempic® imports from Denmark to Russia.

The Ministry of Health of Russia authorizes a Russian anti-melanoma originator

The Ministry of Health of the Russian Federation has authorized a Russian originator drug for the treatment of unresectable or metastatic melanoma. The product was developed by BIOCAD, a biotechnology company; it is a fixed dose combination of two monoclonal antibodies, nurulimab and prolgolimab.

NPO Microgen brings to market new Hepatitis B drug

NPO Microgen as part of Nacimbio Holding got a Registration Certificate by the Ministry of Health of the Russian Federation of a medicinal product...

Production of one of the world’s most sought-after drugs for migraine therapy starts in Moscow

The Russian pharmaceutical company NovaMedica has announced the production and market launch of the first large batch of the drug Relonova® intended for relief of migraine-associated headaches.

GEROPHARM invests 2 billion roubles in medicinal product manufacture in Saint Petersburg

On June 16, GEROPHARM and the Government of Saint Petersburg at SPIEF-2023 signed a cooperation agreement to implement the investment project aimed at expanding the manufacture of medicinal products and increasing their export potential.

GEROPHARM will localize the production of 300 IU/mL insulin glargine in Kazakhstan

On June 8, at the Eurasia – Our Home exhibition, GEROPHARM and Karaganda Pharmaceutical Plant signed a long-term contract to localize the production of...
spot_img

Expert Articles

spot_img